What I Do and Why: HBV Treatment Strategies for Diverse Patient Populations

Download All
Featuring interactive multimedia modules, downloadable slidesets, and expert-authored ClinicalThought commentaries from US and European faculty, this program explores in depth why leading experts make specific HBV management decisions in their own practices and equips learners with key strategies for treating a diverse array of patients.
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Program Director
Steven L. Flamm, MD
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

HBV Management Decisions

In this interactive virtual module, expert faculty discuss how they weigh various patient factors to aid in management decisions for patients with HBV infection; topics include treatment candidacy, individualizing treatment, patient monitoring, and approaches to immune-tolerant HBV infection.

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Program Director
Steven L. Flamm, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: July 7, 2020 Expired: July 6, 2021

Review guideline recommendations and key data on evaluating patient and disease characteristics to inform treatment candidacy and the optimal treatment approach; topics include treatment options, patient monitoring, and approaches to immune-tolerant HBV infection.

Steven L. Flamm, MD Mindie H. Nguyen, MD, MAS, AGAF, FAASLD Released: July 7, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue